Hair Million promotes hair growth in both women and men. It is made of healthy and safe herbs that have been well documented and in use for thousands of years, especially in Asia. Although these herbs have not yet been scientifically proven by placebo-controlled clinical trials nor the ingedients of the herbs charaterized in laboratory, the herbal formula has been proven efficacious anecdotally in a number of people who experience hair thinning and hair loss. There are other herbs and nutritions that also work in anecdotal cases. For instance, Saw palmetto fruit extract have beens shown effective. Other herbs, such as sage, evening primrose, horse chestnut, horsetail, rosemary have been suggested. B vitamins, especially biotin might help as well.

Hair Million is a finest product that would ward off hair loss and promote hair growth, without side effect. Hair Million should be orally taken as suggested for a few months to see the positive effects: stopping hair thinning, and hair loss, and observing new hair growth. For some individuals, none of the hair growth products or methods would work, and the reasons are not always clear. People with alopecia areata would certainly benefit from Hair Million. Once you know it works for you, you could take it for months and years. It often results in complete restoration of hair.



  • Approach to the adult female patient with diffuse nonscarring alopecia.
  • Baldness: Does appearance matter?
  • Hair loss during treatment with oral contraceptives
  • The pattern and profile of alopecia areata in Singapore - a study of 219 Asians.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • The potential role of minoxidil in the hair transplantation setting.
  • Alopecia universalis in a case of systemic lupus erythematosus.
  • Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy.
  • Comparative efficacy of various treatment regimens for androgenetic alopecia in men.
  • The clinical application of scalp expansion in the repair of cicatricial baldness in children
  • Kenogen. A new phase of the hair cycle?
  • Alopecia universalis in a case of systemic lupus erythematosus.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • The potential role of minoxidil in the hair transplantation setting.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Steroidogenic isoenzymes in human hair and their potential role in androgenetic alopecia.
  • Treatment of hyperandrogenic alopecia in women.
  • Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer
  • Postmenopausal frontal fibrosing alopecia.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • The art of repair in surgical hair restoration--part II: the tactics of repair.
  • Loss of cell adhesion in Dsg3bal-Pas mice with homozygous deletion mutation (2079del14) in the desmoglein 3 gene.
  • Disappearance of pili annulati following an episode of alopecia areata.
  • Treatment of hyperandrogenic alopecia in women.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Alopecia areata: update on therapy
  • Baldness: Does appearance matter?
  • Postmenopausal frontal fibrosing alopecia. Report of 3 cases
  • A philosophy and strategy for surgical hair restoration: a 10-year experience.
  • A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
  • Postmenopausal frontal fibrosing alopecia.
  • Implication of VEGF, steroid hormones and neuropeptides in hair follicle cell responses
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • The hair follicle as a target for gene therapy
  • Indications for micrograft hair transplantation
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Effect of minoxidil on hair growth in androgenic alopecia in women
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Hair loss during treatment with oral contraceptives
  • Androgens and alopecia.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans.
  • Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
  • Follicular unit extraction: minimally invasive surgery for hair transplantation.
  • Notch/RBP-J Signaling Regulates Epidermis/Hair Fate Determination of Hair Follicular Stem Cells.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • A random study of Asian male androgenetic alopecia in Bangkok, Thailand.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Fas and c-kit are involved in the control of hair follicle melanocyte apoptosis and migration in chemotherapy-induced hair loss.
  • Treatment of hyperandrogenic alopecia in women.
  • Androgenetic alopecia
  • Molecular mechanisms of androgenetic alopecia.
  • Treatment of hyperandrogenic alopecia in women.
  • Alopecia areata in children: a clinical profile.
  • Acute Diffuse and Total Alopecia of the Female Scalp. a new subtype of diffuse alopecia areata that has a favorable prognosis.
  • Hair pain (trichodynia): frequency and relationship to hair loss and patient gender.
  • Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Role of the Autoimmune Regulator (AIRE) gene in alopecia areata: Strong association of a potentially functional AIRE polymorphism with alopecia universalis.
  • Androgenetic alopecia
  • Primary follicular mucinosis: long-term follow-up of patients younger than 40 years with and without clonal T-cell receptor gene rearrangement.
  • Ultrastructural study of acquired pili torti-like hair defects accompanying pseudopelade.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.
  • Striae distensae - like lesions. A cause of scarring alopecia among children.
  • Androgens and alopecia.
  • Postmenopausal frontal fibrosing alopecia.
  • Clinical relevance of hair microscopy in alopecia.
  • Mouse models for human hair loss disorders.
  • Alopecia areata: update on therapy
  • Langerhans cells that express matrix metalloproteinase 9 increase in human dermis during sensitization to diphenylcyclopropenone in patients with alopecia areata.
  • Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study.



    Hair loss and hair growth online references:

    1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 |